Abstract | AIM: MATERIAL AND METHODS: A total of 50 patients were examined (30 patients in the main group, 20 patients in the control one). All patients received standard therapy with SSRI antidepressants. Rac- hopantenic acid at a daily dose of 1200 mg was included in the complex therapy of patients of the main group. Duration of the therapy with rac- hopantenic acid was 21 days. Psychopathological, psychometric and detailed somatic examinations were performed. RESULTS: CONCLUSION:
|
Authors | A B Gekht, L S Kanaeva, A S Avedisova, M P Marachev, K V Zakharova, G K Dashkina, E V Kulikova |
Journal | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
(Zh Nevrol Psikhiatr Im S S Korsakova)
2016
Vol. 116
Issue 11
Pg. 45-57
ISSN: 1997-7298 [Print] Russia (Federation) |
Vernacular Title | Vozmozhnosti primeneniya rats-gopantenovoi kisloty v kompleksnom lechenii trevozhno-depressivnykh rasstroistv u bol'nykh s khronicheskoi ishemiei golovnogo mozga. |
PMID | 28091501
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Anxiety Agents
- Antidepressive Agents
- Nootropic Agents
- pantogab
- Pantothenic Acid
- gamma-Aminobutyric Acid
|
Topics |
- Anti-Anxiety Agents
- Antidepressive Agents
(therapeutic use)
- Anxiety Disorders
(complications, drug therapy)
- Brain Ischemia
(complications)
- Depressive Disorder
(drug therapy)
- Humans
- Nootropic Agents
- Pantothenic Acid
(analogs & derivatives, therapeutic use)
- Psychometrics
- gamma-Aminobutyric Acid
(analogs & derivatives, therapeutic use)
|